Unknown

Dataset Information

0

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

ABSTRACT: The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.

SUBMITTER: Benson AB 

PROVIDER: S-EPMC10181270 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Benson Al B AB   Venook Alan P AP   Al-Hawary Mahmoud M MM   Cederquist Lynette L   Chen Yi-Jen YJ   Ciombor Kristen K KK   Cohen Stacey S   Cooper Harry S HS   Deming Dustin D   Engstrom Paul F PF   Grem Jean L JL   Grothey Axel A   Hochster Howard S HS   Hoffe Sarah S   Hunt Steven S   Kamel Ahmed A   Kirilcuk Natalie N   Krishnamurthi Smitha S   Messersmith Wells A WA   Meyerhardt Jeffrey J   Mulcahy Mary F MF   Murphy James D JD   Nurkin Steven S   Saltz Leonard L   Sharma Sunil S   Shibata David D   Skibber John M JM   Sofocleous Constantinos T CT   Stoffel Elena M EM   Stotsky-Himelfarb Eden E   Willett Christopher G CG   Wuthrick Evan E   Gregory Kristina M KM   Freedman-Cass Deborah A DA  

Journal of the National Comprehensive Cancer Network : JNCCN 20180701 7

The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gast  ...[more]

Similar Datasets

Unknown Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC9440150 | biostudies-literature
Unknown Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC10203817 | biostudies-literature
Unknown Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC10191161 | biostudies-literature
Unknown Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC11807340 | biostudies-literature
Unknown Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC10186762 | biostudies-literature
Unknown Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
| S-EPMC10203822 | biostudies-literature
Unknown NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
| S-EPMC10191771 | biostudies-literature
Unknown NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
| S-EPMC10184502 | biostudies-literature
Unknown NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
| S-EPMC5557008 | biostudies-literature
Unknown NCCN Guidelines® Insights: Palliative Care, Version 2.2021.
| S-EPMC10196810 | biostudies-literature